Progestins: all 372 studies that test it

Page 3 of 4. Open to participants first (45), then studies with results posted, then the rest; newest registration first within each.

• Dydrogesterone in the Treatment of Endometrial PolypsCompletedNCT03790215Phase 4
• Role of 200 mg Versus 400mg Vaginal Progesterone in Prevention of Preterm Labor in Twin GestationStatus unknownNCT03781674Not applicable
• Effect of Cervical Cerclage With Vaginal Progesterone in Asymptomatic Twin Pregnancies With a Sonographic Short CervixStatus unknownNCT03781466Not applicable
• Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta PreviaStatus unknownNCT03779451Not applicable
• 17-Alpha-Hydroxyprogesterone Caproate in Pregnant Women With Placenta PreviaStatus unknownNCT03779438Not applicable
• The Role of Estrogen in the Neurobiology of Eating DisordersCompletedNCT03740204Phase 2
• Characterization of the Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal WomenCompletedNCT03737656Phase 1
• Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase SupportCompletedNCT03734770Not applicable
• Prolutex in Frozen Embryo Transfer Cycles At the Blastocyst Stage (PROGEX)CompletedNCT03701490Phase 2
• Clinical Study on Endometrial ReceptivityStatus unknownNCT03687021Early Phase 1
• Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVFTerminatedNCT03680053Not applicable
• Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSICompletedNCT03677336Phase 4
• MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without AtypiaCompletedNCT03675139Phase 3
• Progesterone in Patients With Placenta PreviaStatus unknownNCT03633175Phase 2
• Oral Versus Vaginal Progesterone in the Luteal Support in Cryo-warmed Embryo Transfer CyclesCompletedNCT03619707Phase 4
• Vaginal Progesterone for the Prevention of Preterm Birth in TwinsWithdrawnNCT03540225Phase 3
• Different Types of Progesterone in the Prevention of Preterm LaborStatus unknownNCT03537287Phase 2
• Comparison of Coagulation Profiles Between Zoely and Minidoz: RCTTerminatedNCT03531437Phase 4
• Progesterone Supplementation in Frozen Embryo Transfer CyclesStatus unknownNCT03504345Not applicable
• Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist ProtocolStatus unknownNCT03484611Not applicable
• The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI CyclesStatus unknownNCT03457233Not applicable
• The Efficacy of Progestins in Treatment of Functional Ovarian CystStatus unknownNCT03456570Early Phase 1
• Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With LetrozoleCompletedNCT03440359Phase 2/3
• Progesterone to Prevent Preterm DeliveryStatus unknownNCT03428685Phase 2/3
• The Efficacy of Estrogen Therapy Against Adhesion Reformation After Hysteroscopic AdhesiolysisStatus unknownNCT03351205Not applicable
• Comparing the Efficacy of Two Methods in the Prevention of Adhesion Reformation After Hysteroscopic AdhesiolysisStatus unknownNCT03346317Not applicable
• Oral Versus Parental Progesterone in the Management of Preterm LaborCompletedNCT03343795Phase 4
• Pharmacokinetics of Progesterone in PregnancyCompletedNCT03340701Phase 1
• Endometrial Polyps Regression With Progesterone TherapyStatus unknownNCT03309709Phase 3
• Progesterone and Doppler in Recurrent AbortionStatus unknownNCT03267771Phase 4
• Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of ProgesteroneCompletedNCT03211338Not applicable
• Vaginal Progesterone Supplementation in the Management of Preterm LaborCompletedNCT03202836Not applicable
• Study of Progesterone in Treatment of Vasomotor SymptomsTerminatedNCT03202186Phase 3
• Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI CyclesTerminatedNCT03181685Phase 4
• Progesterone and Aminophylline for the Prevention of Preterm LabourStatus unknownNCT03152942Phase 1
• Intramuscular Hydroxyprogesterone Caproate and Placenta PreviaCompletedNCT03130504Phase 2
• Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian SyndromeCompletedNCT03088046Not applicable
• Progesterone and Cervical Pessary in TwinsStatus unknownNCT03058536Phase 2/3
• Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm LaborCompletedNCT02989519Phase 3
• Progesterone in Luteal Phase DeficiencyWithdrawnNCT02950948Phase 3
• Progesterone in Threatened AbortionTerminatedNCT02950935Phase 3
• The Vaginal Progesterone and CerclageCompletedNCT02846909Phase 2
• Efficacy Study of Progesterone Tablet in Post-menopausal WomenCompletedNCT02841137Phase 2
• Subcutaneous Progesterone Supplementation in Patients With EndometriosisStatus unknownNCT02793908Phase 3
• Oral Micronized Progesterone Effects on Perimenopausal Menstrual FlowCompletedNCT02779582Phase 3
• Comparison of Vaginal and Intramuscular Progesterone in Vitrified-warmed Blastocyst Transfer CyclesWithdrawnNCT02772120Phase 4
• Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in DonorsWithdrawnNCT02757287Phase 4
• Vaginal Progesterone in Twin With Short CervixCompletedNCT02697331Phase 3
• Vaginal Progesterone for Treatment of Threatened MiscarriageStatus unknownNCT02690129Not applicable
• Vaginal Progesterone Versus Cervical Cerclage for Pregnant Women With Short Cervix and History of PTL and/or MTMStatus unknownNCT02673359Phase 4
• Cervical Pessary vs. Vaginal Progesterone for Preventing Premature Birth in IVF Twin PregnanciesCompletedNCT02623881Not applicable
• The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm BirthStatus unknownNCT02571296Phase 4
• Russia/Ukraine Suppression of Ovarian Activity StudyCompletedNCT02550977Phase 2
• Effect of Luteal Progesterone Support on Pregnancy Rates With Combined Clomid/ Gonadotropin & IUITerminatedNCT02510534Phase 1
• Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement TherapyCompletedNCT02467673Phase 2
• Vaginal Progesterone Versus Placebo for the Treatment of Vaginal AtrophyWithdrawnNCT02460302Phase 2
• Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term LaborCompletedNCT02430233Phase 4
• Progesterone Supplementation for HIV-positive Pregnant Women on Anti-RetroviralsStatus unknownNCT02400021Phase 2
• Lactoferrin or Progesterone for Prevention of Preterm DeliveryStatus unknownNCT02372942Phase 4
• Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes RecipientsCompletedNCT02363127Phase 4
• Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short CervixCompletedNCT02338830Phase 4
• Comparing Double Dose of Vaginal Progesterone to no Treatment for Prevention of Preterm Birth in Twins and Short CervixTerminatedNCT02329535Not applicable
• Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase SupportCompletedNCT02316626Phase 4
• Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant WomenStatus unknownNCT02304237Phase 3
• Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older WomenCompletedNCT02272647Phase 1
• Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm LaborCompletedNCT02262481Not applicable
• Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT TrialCompletedNCT02145767Phase 2
• Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened MiscarriageCompletedNCT02128685Phase 3
• Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUBStatus unknownNCT02103764Phase 3
• A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal WomenCompletedNCT02092571Phase 1
• The Effect of Different Types of Progestin on Sleeping of Menopausal WomenCompletedNCT02086032Not applicable
• Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone.CompletedNCT02032797Phase 4
• A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary AmenorrheaTerminatedNCT02019589Phase 3
• Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled TrialStatus unknownNCT01985594Phase 2
• Effect of Progestin-Induced Withdrawal Bleed on Ovulation Induction Cycles With Clomiphene CitrateWithdrawnNCT01966575Phase 4
• Substituted Frozen Embryo Transfer Cycles With GnRH-agonist SupplementationCompletedNCT01943812Phase 4
• Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved (Frozen)-Thawed Day 3 Embryos in an Artificial Cycle With Exogenous Estrogen and ProgesteroneCompletedNCT01940653Phase 4
• Preterm Delivery Prevention in Twins With ProgesteroneStatus unknownNCT01927029Phase 4
• Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in BloodCompletedNCT01899846Phase 1
• Intrauterine Insemination and Luteal Fase SupportCompletedNCT01826747Phase 4
• Vaginal Progesterone in Twins With Short CervixWithdrawnNCT01812239Phase 2/3
• Effect of Ultrasound Guided Embryo Transfer on Pregnancy RatesCompletedNCT01810601Not applicable
• Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm DeliveryWithdrawnNCT01796522Phase 3
• Is Adding E2 to P4 Luteal Support In High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Outcome? RCTCompletedNCT01790282Not applicable
• The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular CyclesStatus unknownNCT01780610Not applicable
• A Study:the Different Outcomes Between Natural Cycle and Hormone Replacement Cycle in FETStatus unknownNCT01780558Not applicable
• Progesterone Suppression of Nocturnal LH Increases in Pubertal GirlsCompletedNCT01773772Phase 1
• Progesterone and Atomoxetine for Cocaine CessationWithdrawnNCT01741376Not applicable
• Multi-centre Clinical Trial on Hormone Replacement Treatment in ChinaStatus unknownNCT01698164Phase 4
• Pr-conceptional Progesterone for Unexplained Recurrent MiscarriageCompletedNCT01670929Phase 4
• Prevention of Preterm Birth in Pregnant Women at Risk Identified by Ultrasound: Evaluation of Two Treatment StrategiesCompletedNCT01643980Phase 4
• Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug EffectWithdrawnNCT01589081Not applicable
• Effects of Progesterone on IV Nicotine Induced Changes on BOLD fMRI Signal, Hormones and Subjective Ratings of Stimulant DrugsWithdrawnNCT01589068Not applicable
• Postoperative Desogestrel for Endometriosis Related PainCompletedNCT01559480Not applicable
• Vaginal Progesterone for Prevention of Preterm Birth After an Episode of Preterm LaborCompletedNCT01523483Not applicable
• Endometrial Receptivity After GnRH Agonist TriggeringCompletedNCT01500863Phase 4
• Vaginal Progesterone Versus Progesterone in Oil in Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor EggsCompletedNCT01465373Phase 4
• Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern?Status unknownNCT01438736Phase 4
• Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause WomenCompletedNCT01432028Not applicable
• Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone InhibitionActive, not recruitingNCT01425541Not applicable

← Progestins overview